Harvard Bioscience Inc (HBIO): Next-Year EPS Estimate 162.86%
As of 2026-06-11, Harvard Bioscience Inc (HBIO) has a next-year EPS growth estimate of 162.86%.
On 2026-05-13, analyst consensus for HBIO's next-year EPS growth shifted from 119.29% to 162.86% — a positive change of 43.57 percentage points. The revised estimate has been sustained across 22 subsequent trading sessions. Current-year growth is projected at -250.00%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- EPS growth next year
- 162.86%
- EPS growth this year
- -250.00%
- EPS next quarter (est)
- -$0.21
- Last price
- $6.64
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 162.86% | -250.00% | -$0.21 | $6.64 |
| 2026-06-10 | 162.86% | -250.00% | -$0.21 | $6.20 |
| 2026-06-09 | 162.86% | -250.00% | -$0.21 | $6.04 |
| 2026-06-08 | 162.86% | -250.00% | -$0.21 | $6.01 |
| 2026-06-07 | 162.86% | -250.00% | -$0.21 | $6.20 |
| 2026-06-04 | 162.86% | -250.00% | -$0.21 | $6.48 |
| 2026-06-03 | 162.86% | -250.00% | -$0.21 | $6.50 |
| 2026-06-02 | 162.86% | -250.00% | -$0.21 | $6.46 |
| 2026-06-01 | 162.86% | -250.00% | -$0.21 | $6.40 |
| 2026-05-31 | 162.86% | -250.00% | -$0.21 | $5.88 |
| 2026-05-28 | 162.86% | -250.00% | -$0.21 | $5.95 |
| 2026-05-27 | 162.86% | -250.00% | -$0.21 | $5.78 |
| 2026-05-26 | 162.86% | -250.00% | -$0.21 | $5.68 |
| 2026-05-25 | 162.86% | -250.00% | -$0.21 | $5.59 |
| 2026-05-24 | 162.86% | -250.00% | -$0.21 | $5.59 |
| 2026-05-21 | 162.86% | -250.00% | -$0.21 | $5.52 |
| 2026-05-20 | 162.86% | -250.00% | -$0.21 | $5.40 |
| 2026-05-19 | 162.86% | -250.00% | -$0.21 | $5.01 |
| 2026-05-18 | 162.86% | -250.00% | -$0.21 | $5.00 |
| 2026-05-17 | 162.86% | -250.00% | -$0.21 | $5.25 |
| 2026-05-14 | 162.86% | -250.00% | -$0.21 | $5.52 |
| 2026-05-13 | 162.86% | -250.00% | -$0.21 | $5.66 |
| 2026-05-12 | 119.29% | -677.50% | -$0.42 | $5.41 |
| 2026-05-11 | 159.64% | -587.50% | -$0.62 | $6.84 |
| 2026-05-10 | 159.64% | -587.50% | -$0.62 | $6.89 |
| 2026-05-07 | 159.64% | -587.50% | -$0.62 | $6.79 |
| 2026-05-06 | 159.64% | -587.50% | -$0.62 | $7.24 |
| 2026-05-05 | 159.64% | -587.50% | -$0.62 | $6.63 |
| 2026-05-04 | 159.64% | -587.50% | -$0.62 | $6.40 |
| 2026-05-03 | 159.64% | -587.50% | -$0.62 | $6.36 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Harvard Bioscience Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Harvard Bioscience Inc (HBIO) has a next-year EPS growth estimate of 162.86%, based on analyst consensus.
When was the latest EPS estimate revision for HBIO?▾
The most recent revision occurred on 2026-05-13, when analysts adjusted the next-year EPS growth estimate from 119.29% to 162.86%.
What sector and industry does Harvard Bioscience Inc belong to?▾
Harvard Bioscience Inc operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. HBIO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Harvard Bioscience Inc (HBIO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports